Medistem's P2P Acquisition

Medistem raised a round of funding on March 07, 2014. Investors include Intrexon.

Medistem, Inc. is developing ERC-124, a universal stem cell product derived from the endometrium. ERC-124 possesses specialized abilities to stimulate new blood vessel formation and can differentiate…

Articles about Medistem's P2P Acquisition: